BRAIN Biotech AG
XETRA:BNN
BRAIN Biotech AG
Common Shares Outstanding
BRAIN Biotech AG
Common Shares Outstanding Peer Comparison
Competitive Common Shares Outstanding Analysis
Latest Figures & CAGR of Competitors
Company | Common Shares Outstanding | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BRAIN Biotech AG
XETRA:BNN
|
Common Shares Outstanding
€21.8m
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
Wacker Chemie AG
XETRA:WCH
|
Common Shares Outstanding
€49.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Evonik Industries AG
XETRA:EVK
|
Common Shares Outstanding
€466m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
Covestro AG
XETRA:1COV
|
Common Shares Outstanding
€188.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
AlzChem Group AG
XETRA:ACT
|
Common Shares Outstanding
€10.2m
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Symrise AG
XETRA:SY1
|
Common Shares Outstanding
€139.8m
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
2%
|
See Also
What is BRAIN Biotech AG's Common Shares Outstanding?
Common Shares Outstanding
21.8m
EUR
Based on the financial report for Dec 31, 2023, BRAIN Biotech AG's Common Shares Outstanding amounts to 21.8m EUR.
What is BRAIN Biotech AG's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
4%
Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for BRAIN Biotech AG have been 3% over the past three years , 4% over the past five years .